196 related articles for article (PubMed ID: 31438848)
1. Influence of batch effect correction methods on drug induced differential gene expression profiles.
Zhou W; Koudijs KKM; Böhringer S
BMC Bioinformatics; 2019 Aug; 20(1):437. PubMed ID: 31438848
[TBL] [Abstract][Full Text] [Related]
2. A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data.
Wang F; Lei X; Wu FX
Curr Med Chem; 2020; 27(32):5340-5350. PubMed ID: 30381060
[TBL] [Abstract][Full Text] [Related]
3. Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning.
He J; Yan H; Cai H; Li X; Guan Q; Zheng W; Chen R; Liu H; Song K; Guo Z; Wang X
J Transl Med; 2017 Sep; 15(1):198. PubMed ID: 28962576
[TBL] [Abstract][Full Text] [Related]
4. Identifying Gene Signatures for Cancer Drug Repositioning Based on Sample Clustering.
Wang F; Ding Y; Lei X; Liao B; Wu FX
IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(2):953-965. PubMed ID: 32845842
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
6. Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes.
Xu C; Ai D; Shi D; Suo S; Chen X; Yan Y; Cao Y; Zhang R; Sun N; Chen W; McDermott J; Zhang S; Zeng Y; Han JJ
Cell Rep; 2018 Oct; 25(2):523-535.e5. PubMed ID: 30304690
[TBL] [Abstract][Full Text] [Related]
7. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
8. DrugSig: A resource for computational drug repositioning utilizing gene expression signatures.
Wu H; Huang J; Zhong Y; Huang Q
PLoS One; 2017; 12(5):e0177743. PubMed ID: 28562632
[TBL] [Abstract][Full Text] [Related]
9. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
[TBL] [Abstract][Full Text] [Related]
10. ksRepo: a generalized platform for computational drug repositioning.
Brown AS; Kong SW; Kohane IS; Patel CJ
BMC Bioinformatics; 2016 Feb; 17():78. PubMed ID: 26860211
[TBL] [Abstract][Full Text] [Related]
11. A review of connectivity map and computational approaches in pharmacogenomics.
Musa A; Ghoraie LS; Zhang SD; Glazko G; Yli-Harja O; Dehmer M; Haibe-Kains B; Emmert-Streib F
Brief Bioinform; 2018 May; 19(3):506-523. PubMed ID: 28069634
[TBL] [Abstract][Full Text] [Related]
12. Human Protein Complex-Based Drug Signatures for Personalized Cancer Medicine.
Wang F; Ding Y; Lei X; Liao B; Wu FX
IEEE J Biomed Health Inform; 2021 Nov; 25(11):4079-4088. PubMed ID: 34665747
[TBL] [Abstract][Full Text] [Related]
13. Network-based inference methods for drug repositioning.
Chen H; Zhang H; Zhang Z; Cao Y; Tang W
Comput Math Methods Med; 2015; 2015():130620. PubMed ID: 25969690
[TBL] [Abstract][Full Text] [Related]
14. Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma.
Zhu FX; He YC; Zhang JY; Wang HF; Zhong C; Wang XT
Med Sci Monit; 2019 May; 25():3247-3255. PubMed ID: 31048671
[TBL] [Abstract][Full Text] [Related]
15. Drug Repositioning for Cancer Therapy Based on Large-Scale Drug-Induced Transcriptional Signatures.
Lee H; Kang S; Kim W
PLoS One; 2016; 11(3):e0150460. PubMed ID: 26954019
[TBL] [Abstract][Full Text] [Related]
16. Multi-target drug repositioning by bipartite block-wise sparse multi-task learning.
Li L; He X; Borgwardt K
BMC Syst Biol; 2018 Apr; 12(Suppl 4):55. PubMed ID: 29745839
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive evaluation of connectivity methods for L1000 data.
Lin K; Li L; Dai Y; Wang H; Teng S; Bao X; Lu ZJ; Wang D
Brief Bioinform; 2020 Dec; 21(6):2194-2205. PubMed ID: 31774912
[TBL] [Abstract][Full Text] [Related]
18. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
[TBL] [Abstract][Full Text] [Related]
19. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer.
Yang C; Zhang H; Chen M; Wang S; Qian R; Zhang L; Huang X; Wang J; Liu Z; Qin W; Wang C; Hang H; Wang H
Elife; 2022 Feb; 11():. PubMed ID: 35191375
[TBL] [Abstract][Full Text] [Related]
20. Integrating LINCS Data to Evaluate Cancer Transcriptome Modifying Potential of Small-molecule Compounds for Drug Repositioning.
Zhao Y; Liu Y; Bai H
Comb Chem High Throughput Screen; 2021; 24(9):1340-1350. PubMed ID: 33109034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
